Elanco Animal Health Incorporated (ELAN) Financials

NYSE:ELAN

Market Cap

5.84B

Total Revenue

4.42B

Gross Profit

2.50B

Operating Income

358.00M

Net Income

-74.00M

Metric	2015	2016	2017	2018	2019	2020	2021	2022
revenue	2,909,100,000	2,913,500,000	2,889,000,000	3,066,800,000	3,071,000,000	3,273,300,000	4,765,000,000	4,418,000,000
costOfRevenue	1,533,700,000	1,409,000,000	1,493,900,000	1,573,800,000	1,470,300,000	1,666,600,000	2,134,000,000	1,913,000,000
grossProfit	1,375,400,000	1,504,500,000	1,395,100,000	1,493,000,000	1,600,700,000	1,606,700,000	2,631,000,000	2,505,000,000
researchAndDevelopmentExpenses	291,000,000	265,800,000	251,700,000	246,600,000	270,100,000	327,000,000	369,000,000	321,000,000
sellingAndMarketingExpenses	--	--	--	--	--	--	--	--
generalAndAdministrativeExpenses	--	--	--	735,200,000	--	--	--	--
sellingGeneralAndAdministrativeExpenses	916,000,000	784,800,000	779,800,000	735,200,000	760,200,000	996,600,000	1,404,000,000	1,266,000,000
operatingExpenses	1,370,000,000	1,221,300,000	1,252,700,000	1,179,200,000	1,230,700,000	1,683,500,000	2,329,000,000	2,115,000,000
operatingIncome	5,400,000	283,200,000	142,400,000	313,800,000	342,600,000	101,500,000	297,000,000	358,000,000
totalOtherIncomeExpensesNet	-264,900,000	-305,600,000	-375,000,000	-170,100,000	-264,400,000	-773,500,000	-864,000,000	-424,000,000
ebitda	505,600,000	540,400,000	835,900,000	640,000,000	543,000,000	461,400,000	853,000,000	886,000,000
depreciationAndAmortization	236,900,000	254,400,000	318,400,000	197,400,000	200,400,000	359,900,000	556,000,000	528,000,000
interestIncome	--	--	--	--	--	--	--	--
interestExpense	--	--	--	29,600,000	78,900,000	149,800,000	236,000,000	241,000,000
incomeBeforeTax	-259,500,000	-22,400,000	-232,600,000	114,100,000	78,200,000	-672,000,000	-567,000,000	-66,000,000
incomeTaxExpense	-48,700,000	25,500,000	78,100,000	27,600,000	10,300,000	-111,900,000	-95,000,000	8,000,000
netIncome	-210,800,000	-47,900,000	-310,700,000	86,500,000	67,900,000	-560,100,000	-472,000,000	-74,000,000
eps	-0.59	-0.13	-0.87	0.28	0.18	-1.27	-0.97	-0.15
epsdiluted	-0.59	-0.13	-0.87	0.28	0.18	-1.27	-0.97	-0.15
weightedAverageShsOut	356,200,000	356,200,000	356,200,000	313,700,000	369,000,000	441,400,000	487,200,000	488,300,000
weightedAverageShsOutDil	356,200,000	356,200,000	356,200,000	313,700,000	370,300,000	441,400,000	487,200,000	488,300,000
costAndExpenses	2,903,700,000	2,630,300,000	2,746,600,000	2,753,000,000	2,701,000,000	3,350,100,000	4,463,000,000	4,028,000,000
otherExpenses	-1,600,000	2,800,000	100,000	-41,300,000	200,400,000	359,900,000	556,000,000	528,000,000

Key Facts

Industry

Drug Manufacturers—Specialty & Generic

Sector

Healthcare

Headquarters

Greenfield, IN, US

Website

elanco.com

CEO

Mr. Jeffrey N. Simmons

Employees

9000

About the Company

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.